LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 58.88 | 84.90 | 3917 | 7291 | 0.5372 | 0.8156 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 60.59 | 84.90 | 3251 | 7641 | 0.4254 | 0.7533 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 60.59 | 84.90 | 3275 | 7641 | 0.4286 | 0.7553 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 60.59 | 84.90 | 441 | 7641 | 0.0577 | 0.2889 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 60.59 | 84.90 | 4155 | 7641 | 0.5437 | 0.8208 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 62.29 | 84.90 | 3460 | 7934 | 0.4361 | 0.7619 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 62.29 | 84.90 | 3485 | 7934 | 0.4392 | 0.7638 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 62.29 | 84.90 | 425 | 7934 | 0.0536 | 0.2790 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 62.29 | 84.90 | 4364 | 7934 | 0.5500 | 0.8254 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 63.99 | 84.90 | 3616 | 8212 | 0.4403 | 0.7661 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 63.99 | 84.90 | 3638 | 8212 | 0.4430 | 0.7678 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 63.99 | 84.90 | 465 | 8212 | 0.0566 | 0.2941 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 63.99 | 84.90 | 4599 | 8212 | 0.5600 | 0.8317 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 65.70 | 84.90 | 3783 | 8484 | 0.4459 | 0.7710 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 65.70 | 84.90 | 3810 | 8484 | 0.4491 | 0.7729 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 65.70 | 84.90 | 478 | 8484 | 0.0563 | 0.2971 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 65.70 | 84.90 | 4752 | 8484 | 0.5601 | 0.8329 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 67.41 | 84.90 | 3932 | 8766 | 0.4485 | 0.7741 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 67.41 | 84.90 | 3965 | 8766 | 0.4523 | 0.7763 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 67.41 | 84.90 | 497 | 8766 | 0.0567 | 0.3023 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 67.41 | 84.90 | 4995 | 8766 | 0.5698 | 0.8387 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 69.11 | 84.90 | 4106 | 8988 | 0.4568 | 0.7801 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 69.11 | 84.90 | 4132 | 8988 | 0.4597 | 0.7818 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 69.11 | 84.90 | 546 | 8988 | 0.0607 | 0.3188 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 69.11 | 84.90 | 5186 | 8988 | 0.5770 | 0.8430 | MN20160318_Q02 | H18 |